You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

20 Items
Cancer Type: Hematologic, Lymphoma - T-cell     
Intent: Curative, Palliative
Nov 2017
Cancer Type: Sarcoma, Soft Tissue     
Intent: Neoadjuvant, Adjuvant, Palliative
Apr 2016
Cancer Type: Gynecologic, Uterine Sarcoma, Sarcoma, Uterine     
Intent: Palliative
Nov 2017
Cancer Type: Sarcoma, Soft Tissue     
Intent: Adjuvant
Apr 2016
Cancer Type: Sarcoma, Ewing's, Soft Tissue     
Intent: Neoadjuvant, Adjuvant, Palliative
Feb 2018
Cancer Type: Hematologic, Lymphoma - Hodgkin     
Intent: Curative, Palliative
Mar 2018
Cancer Type: Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade     
Intent: Curative
Mar 2018
Cancer Type: Sarcoma, Ewing's, Soft Tissue     
Intent: Neoadjuvant, Adjuvant, Palliative
Jan 2018
Cancer Type: Gynecologic, Uterine Sarcoma, Sarcoma, Uterine     
Intent: Palliative
Feb 2018
Cancer Type: Sarcoma, Osteogenic / Bone, Soft Tissue     
Intent: Palliative
Nov 2017
Cancer Type: Gynecologic, Endometrial     
Intent: Palliative
Oct 2017
Cancer Type: Hematologic, Lymphoma - T-cell     
Intent: Curative
Jan 2018